|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H,
Liu X, Le H and Zhang Y: Diagnostic value of serum miR-182,
miR-183, miR-210, and miR-126 levels in patients with early-stage
non-small cell lung cancer. PLoS One. 11:e01530462016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scagliotti GV, Fossati R, Torri V, Crinò
L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F and
Tonato M; Adjuvant Lung Project Italy/European Organisation for
Research Treatment of Cancer - Lung Cancer Cooperative Group
Investigators, : Randomized study of adjuvant chemotherapy for
completely resected stage I, II, or IIIA non-small cell lung
cancer. J Natl Cancer Inst. 95:1453–1461. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Verberne CJ, Wiggers T, Grossmann I, de
Bock GH and Vermeulen KM: Cost-effectiveness of a carcinoembryonic
antigen (CEA) based follow-up programme for colorectal cancer (the
CEA Watch trial). Colorectal Dis. 18:O91–O96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang W, Xu X, Tian B, Wang Y, Du L, Sun T,
Shi Y, Zhao X and Jing J: The diagnostic value of serum tumor
markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast
cancer. Clin Chim Acta. 470:51–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grunnet M and Sorensen JB:
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung
Cancer. 76:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferreira LB, Lima RT, da Fonseca Bastos
AC, Silva AM, Tavares C, Pestana A, Rios E, Eloy C, Sobrinho-Simões
M, Etel Gimba RP, et al: OPNa variant expression is associated with
matrix mineralization in thyroid cancer cell lines. Cancer Res. Jul
1–2018.(Epub ahead of print). doi:
10.1158/1538-7445.AM2018-180.
|
|
8
|
Fan Y, Cai W, Li S and Zhang L: Effect of
Ubumex combined with AC-T sequential chemotherapy on serum T cell
subsets. OPN levels and quality of life in patients with triple
negative breast cancer. Proceedings of 2018 International
Conference on Biomedical Engineering, Machinery and Earth Science
(BEMES 2018). Francis Academic Press. (UK). 2018.
|
|
9
|
Byeon H, Lee SD, Hong EK, Lee DE, Kim BH,
Seo Y, Joo J, Han SS, Kim SH, Park SJ, et al: Long-term prognostic
impact of osteopontin and Dickkopf-related protein 1 in patients
with hepatocellular carcinoma after hepatectomy. Pathol Res Pract.
214:814–820. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clemente N, Raineri D, Cappellano G,
Boggio E, Favero F, Soluri MF, Dianzani C, Comi C, Dianzani U and
Chiocchetti A: Osteopontin bridging innate and adaptive immunity in
autoimmune diseases. J Immunol Res. 2016:76754372016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin H, Wang R, Wei G, Wang H, Pan G, Hu R,
Wei Y, Tang R and Wang J: Overexpression of osteopontin promotes
cell proliferation and migration in human nasopharyngeal carcinoma
and is associated with poor prognosis. Eur Arch Otorhinolaryngol.
275:525–534. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cabiati M, Gaggini M, Cesare MM, Caselli
C, De Simone P, Filipponi F, Basta G, Gastaldelli A and Del Ry S:
Osteopontin in hepatocellular carcinoma: A possible biomarker for
diagnosis and follow-up. Cytokine. 99:59–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rouanne M, Adam J, Goubar A, Robin A,
Ohana C, Louvet E, Cormier J, Mercier O, Dorfmüller P, Fattal S, et
al: Osteopontin and thrombospondin-1 play opposite roles in
promoting tumor aggressiveness of primary resected non-small cell
lung cancer. BMC Cancer. 16:4832016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jumpertz S, Hennes T, Asare Y, Schütz AK
and Bernhagen J: CSN5/JAB1 suppresses the WNT inhibitor DKK1 in
colorectal cancer cells. Cell Signal. 34:38–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia X, Li N, Peng C, Deng Y, Wang J, Deng
M, Lu M, Yin J, Zheng G, Liu H, et al: miR-493 mediated DKK1
down-regulation confers proliferation, invasion and
chemo-resistance in gastric cancer. Oncotarget. 7:7044–7054. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yi N, Liao QP, Li T and Xiong Y: Novel
expression profiles and invasiveness-related biology function of
DKK1 in endometrial carcinoma. Oncol Rep. 21:1421–1427.
2009.PubMed/NCBI
|
|
17
|
Yamabuki T, Takano A, Hayama S, Ishikawa
N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, et al:
Dikkopf-1 as a novel serologic and prognostic biomarker for lung
and esophageal carcinomas. Cancer Res. 67:2517–2525. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kasoha M, Bohle RM, Seibold A, Gerlinger
C, Juhasz-Böss I and Solomayer EF: Dickkopf-1 (Dkk1) protein
expression in breast cancer with special reference to bone
metastases. Clin Exp Metastasis. 35:763–775. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakabe T, Azumi J, Umekita Y, Toriguchi K,
Hatano E, Hirooka Y and Shiota G: Expression of cancer stem
cell-associated DKK1 mRNA serves as prognostic marker for
hepatocellular carcinoma. Anticancer Res. 37:4881–4888.
2017.PubMed/NCBI
|
|
20
|
Edge SB, Byrd DR, Carducci MA, Compton CC,
Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual.
Springer; New York, NY: 2010
|
|
21
|
Lei L, Chen Q, Wang Z, Han N, Chen B, Qin
J and Lu HY: Usefulness of carcinoembryonic antigen in the
diagnosis of small cell lung cancer combined with adenocarcinoma.
Advances in Clinical and Experimental Medicine: Official Organ
Wroclaw Medical University. 26:1091–1094. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin Q, Guo L, Lin G, Chen Z, Chen T, Lin
J, Zhang B and Gu X: Clinical and prognostic significance of OPN
and VEGF expression in patients with non-small-cell lung cancer.
Cancer Epidemiol. 39:539–544. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sheng SL, Huang G, Yu B and Qin WX:
Clinical significance and prognostic value of serum Dickkopf-1
concentrations in patients with lung cancer. Clin Chem.
55:1656–1664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma L, Xie XW, Wang HY, Ma LY and Wen ZG:
Clinical evaluation of tumor markers for diagnosis in patients with
non-small cell lung cancer in China. Asian Pac J Cancer Prev.
16:4891–4894. 2015. View Article : Google Scholar : PubMed/NCBI
|
